Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancerF Bonnetain, O Bouché, P Michel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancerJ M Blazeby, T Conroy, E Hammerlid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomasR Fety, F Rolland, M Barberi-Heyob, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2007
Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaireS Gujral, T Conroy, C Fleissner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)M Ducreux, A Adenis, J-P Pignon, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerH Bleiberg, T Conroy, B Paillot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2012
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?F Bonnetain, J F Bosset, J P Gerard, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG studyD J Wagener, W J Hoogenraad, P Rougier, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancerC Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II studyT D Nguyen, S Theobald, P Rougier, et al.
Pageof 15